0001179110-19-010410.txt : 20190917 0001179110-19-010410.hdr.sgml : 20190917 20190917163009 ACCESSION NUMBER: 0001179110-19-010410 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190916 FILED AS OF DATE: 20190917 DATE AS OF CHANGE: 20190917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Munch Mark CENTRAL INDEX KEY: 0001544635 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 191097402 MAIL ADDRESS: STREET 1: BRUKER CORPORATION STREET 2: 40 MANNING ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 4 1 edgar.xml FORM 4 - X0306 4 2019-09-16 0 0001109354 BRUKER CORP BRKR 0001544635 Munch Mark BRUKER CORPORATION 40 MANNING ROAD BILLERICA MA 01821 0 1 0 0 Exec VP&Pres Bruker Nano Inc. Common Stock 2019-09-16 4 M 0 15059 20.04 A 96063 D Common Stock 2019-09-16 4 M 0 16144 20.68 A 112207 D Common Stock 2019-09-16 4 M 0 16000 19.82 A 128207 D Common Stock 2019-09-16 4 S 0 47203 42.8652 D 81004 D Stock Option (Right to Buy) 20.04 2019-09-16 4 M 0 15059 0 D 2023-08-30 Common Stock 15059 0 D Stock Option (Right to Buy) 20.68 2019-09-16 4 M 0 16144 0 D 2024-08-08 Common Stock 16144 0 D Stock Option (Right to Buy) 19.82 2019-09-16 4 M 0 16000 0 D 2025-08-07 Common Stock 16000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.74 to $43.045, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vested in four approximately equal annual installments on August 30, 2014, 2015, 2016 and 2017. The option vested in four approximately equal annual installments on August 8, 2015, 2016, 2017 and 2018. The option vested in four approximately equal annual installments on August 7, 2016, 2017, 2018 and 2019. /s/ Michael Rich, Attorney-in-Fact 2019-09-17